Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 2
1981 4
1982 1
1983 1
1984 3
1986 3
1987 3
1988 4
1989 2
1990 4
1991 2
1992 8
1993 3
1994 2
1995 4
1996 14
1997 7
1998 14
1999 8
2000 12
2001 14
2002 21
2003 30
2004 18
2005 19
2006 24
2007 21
2008 20
2009 13
2010 19
2011 34
2012 29
2013 45
2014 38
2015 31
2016 33
2017 45
2018 46
2019 34
2020 41
2021 44
2022 34
2023 29
2024 31
2025 25

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

727 results

Results by year

Filters applied: . Clear all
Page 1
International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM).
Mateos MV, Kumar S, Dimopoulos MA, González-Calle V, Kastritis E, Hajek R, De Larrea CF, Morgan GJ, Merlini G, Goldschmidt H, Geraldes C, Gozzetti A, Kyriakou C, Garderet L, Hansson M, Zamagni E, Fantl D, Leleu X, Kim BS, Esteves G, Ludwig H, Usmani S, Min CK, Qi M, Ukropec J, Weiss BM, Rajkumar SV, Durie BGM, San-Miguel J. Mateos MV, et al. Among authors: morgan gj. Blood Cancer J. 2020 Oct 16;10(10):102. doi: 10.1038/s41408-020-00366-3. Blood Cancer J. 2020. PMID: 33067414 Free PMC article.
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.
van Dongen JJ, Langerak AW, Brüggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, García-Sanz R, van Krieken JH, Droese J, González D, Bastard C, White HE, Spaargaren M, González M, Parreira A, Smith JL, Morgan GJ, Kneba M, Macintyre EA. van Dongen JJ, et al. Among authors: morgan gj. Leukemia. 2003 Dec;17(12):2257-317. doi: 10.1038/sj.leu.2403202. Leukemia. 2003. PMID: 14671650 Review.
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens.
Maura F, Boyle EM, Coffey D, Maclachlan K, Gagler D, Diamond B, Ghamlouch H, Blaney P, Ziccheddu B, Cirrincione A, Chojnacka M, Wang Y, Siegel A, Hoffman JE, Kazandjian D, Hassoun H, Guzman E, Mailankody S, Shah UA, Tan C, Hultcrantz M, Scordo M, Shah GL, Landau H, Chung DJ, Giralt S, Zhang Y, Arbini A, Gao Q, Roshal M, Dogan A, Lesokhin AM, Davies FE, Usmani SZ, Korde N, Morgan GJ, Landgren O. Maura F, et al. Among authors: morgan gj. Nat Cancer. 2023 Dec;4(12):1660-1674. doi: 10.1038/s43018-023-00657-1. Epub 2023 Nov 9. Nat Cancer. 2023. PMID: 37945755 Free PMC article.
Ameloblastic Carcinoma.
Gunaratne DA, Coleman HG, Lim L, Morgan GJ. Gunaratne DA, et al. Among authors: morgan gj. Am J Case Rep. 2015 Jul 1;16:415-9. doi: 10.12659/AJCR.893918. Am J Case Rep. 2015. PMID: 26126621 Free PMC article.
Temporal Genomic Dynamics Shape Clinical Trajectory in Multiple Myeloma.
Maura F, Kaddoura M, Poos AM, Baughn LB, Ziccheddu B, Bärtsch MA, Cirrincione A, Maclachlan K, Chojnacka M, Diamond B, Papadimitriou M, Blaney P, John L, Reichert P, Huhn S, Gagler D, Zhang Y, Dogan A, Lesokhin AM, Davies F, Goldschmidt H, Fenk R, Weisel KC, Mai EK, Korde N, Morgan GJ, Rajkumar SV, Kumar S, Usmani S, Landgren O, Raab MS, Weinhold N. Maura F, et al. Among authors: morgan gj. bioRxiv [Preprint]. 2024 Sep 4:2024.08.30.610457. doi: 10.1101/2024.08.30.610457. bioRxiv. 2024. Update in: Nat Genet. 2025 Sep;57(9):2203-2214. doi: 10.1038/s41588-025-02292-1. PMID: 39282268 Free PMC article. Updated. Preprint.
Temporal genomic dynamics shape clinical trajectory in multiple myeloma.
Maura F, Kaddoura M, Poos AM, Baughn LB, Ziccheddu B, Bärtsch MA, Cirrincione A, Maclachlan K, Chojnacka M, Diamond B, Papadimitriou M, Blaney P, John L, Reichert P, Huhn S, Gagler D, Zhang Y, Dogan A, Lesokhin AM, Davies F, Goldschmidt H, Fenk R, Weisel KC, Mai EK, Korde N, Morgan GJ, Rajkumar SV, Kumar S, Usmani S, Landgren O, Raab MS, Weinhold N. Maura F, et al. Among authors: morgan gj. Nat Genet. 2025 Sep;57(9):2203-2214. doi: 10.1038/s41588-025-02292-1. Epub 2025 Aug 20. Nat Genet. 2025. PMID: 40835892
A multiomic analysis of Waldenström macroglobulinemia defines distinct disease subtypes.
Gagler DC, Ghamlouch H, Zhang D, Blaney P, Tenenbaum A, Langton J, Armand M, Eeckhoutte A, Joudat A, Degaud M, Esposito M, Varma G, Wang Y, Lee S, Liu S, Lahoud O, Kaminetzky D, Braunstein M, Williams L, Nguyen-Khac F, Walker B, Roos-Weil D, Davies FE, Bernard OA, Morgan GJ. Gagler DC, et al. Among authors: morgan gj. Blood. 2025 Sep 4;146(10):1225-1238. doi: 10.1182/blood.2024028164. Blood. 2025. PMID: 40332467
The genomic features associated with high-risk multiple myeloma.
Walker BA, Morgan GJ. Walker BA, et al. Among authors: morgan gj. Oncotarget. 2018 Oct 26;9(84):35478-35479. doi: 10.18632/oncotarget.26269. eCollection 2018 Oct 26. Oncotarget. 2018. PMID: 30464803 Free PMC article. No abstract available.
The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma.
Cirrincione AM, Poos AM, Ziccheddu B, Kaddoura M, Bärtsch MA, Maclachlan K, Chojnacka M, Diamond B, John L, Reichert P, Huhn S, Blaney P, Gagler D, Rippe K, Zhang Y, Dogan A, Lesokhin AM, Davies F, Goldschmidt H, Fenk R, Weisel KC, Mai EK, Korde N, Morgan GJ, Usmani S, Landgren O, Raab MS, Weinhold N, Maura F. Cirrincione AM, et al. Among authors: morgan gj. Blood. 2024 Aug 15;144(7):771-783. doi: 10.1182/blood.2024024299. Blood. 2024. PMID: 38728430 Free PMC article.
727 results